Cargando…
Correction: Pomalidomide, bortezomib, and low-dose dexamethasone in lenalidomide-refractory and proteasome inhibitor-exposed myeloma
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887838/ https://www.ncbi.nlm.nih.gov/pubmed/30218008 http://dx.doi.org/10.1038/s41375-018-0235-5 |
_version_ | 1783475100969861120 |
---|---|
author | Richardson, P. G. Hofmeister, C. C. Raje, N. S. Siegel, D. S. Lonial, S. Laubach, J. Efebera, Y. A. Vesole, D. H. Nooka, A. K. Rosenblatt, J. Doss, D. Zaki, M. H. Bensmaine, A. Herring, J. Li, Y. Watkins, L. Chen, M. S. Anderson, K. C. |
author_facet | Richardson, P. G. Hofmeister, C. C. Raje, N. S. Siegel, D. S. Lonial, S. Laubach, J. Efebera, Y. A. Vesole, D. H. Nooka, A. K. Rosenblatt, J. Doss, D. Zaki, M. H. Bensmaine, A. Herring, J. Li, Y. Watkins, L. Chen, M. S. Anderson, K. C. |
author_sort | Richardson, P. G. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6887838 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-68878382019-12-05 Correction: Pomalidomide, bortezomib, and low-dose dexamethasone in lenalidomide-refractory and proteasome inhibitor-exposed myeloma Richardson, P. G. Hofmeister, C. C. Raje, N. S. Siegel, D. S. Lonial, S. Laubach, J. Efebera, Y. A. Vesole, D. H. Nooka, A. K. Rosenblatt, J. Doss, D. Zaki, M. H. Bensmaine, A. Herring, J. Li, Y. Watkins, L. Chen, M. S. Anderson, K. C. Leukemia Correction Nature Publishing Group UK 2018-09-14 2018 /pmc/articles/PMC6887838/ /pubmed/30218008 http://dx.doi.org/10.1038/s41375-018-0235-5 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Correction Richardson, P. G. Hofmeister, C. C. Raje, N. S. Siegel, D. S. Lonial, S. Laubach, J. Efebera, Y. A. Vesole, D. H. Nooka, A. K. Rosenblatt, J. Doss, D. Zaki, M. H. Bensmaine, A. Herring, J. Li, Y. Watkins, L. Chen, M. S. Anderson, K. C. Correction: Pomalidomide, bortezomib, and low-dose dexamethasone in lenalidomide-refractory and proteasome inhibitor-exposed myeloma |
title | Correction: Pomalidomide, bortezomib, and low-dose dexamethasone in lenalidomide-refractory and proteasome inhibitor-exposed myeloma |
title_full | Correction: Pomalidomide, bortezomib, and low-dose dexamethasone in lenalidomide-refractory and proteasome inhibitor-exposed myeloma |
title_fullStr | Correction: Pomalidomide, bortezomib, and low-dose dexamethasone in lenalidomide-refractory and proteasome inhibitor-exposed myeloma |
title_full_unstemmed | Correction: Pomalidomide, bortezomib, and low-dose dexamethasone in lenalidomide-refractory and proteasome inhibitor-exposed myeloma |
title_short | Correction: Pomalidomide, bortezomib, and low-dose dexamethasone in lenalidomide-refractory and proteasome inhibitor-exposed myeloma |
title_sort | correction: pomalidomide, bortezomib, and low-dose dexamethasone in lenalidomide-refractory and proteasome inhibitor-exposed myeloma |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887838/ https://www.ncbi.nlm.nih.gov/pubmed/30218008 http://dx.doi.org/10.1038/s41375-018-0235-5 |
work_keys_str_mv | AT richardsonpg correctionpomalidomidebortezomibandlowdosedexamethasoneinlenalidomiderefractoryandproteasomeinhibitorexposedmyeloma AT hofmeistercc correctionpomalidomidebortezomibandlowdosedexamethasoneinlenalidomiderefractoryandproteasomeinhibitorexposedmyeloma AT rajens correctionpomalidomidebortezomibandlowdosedexamethasoneinlenalidomiderefractoryandproteasomeinhibitorexposedmyeloma AT siegelds correctionpomalidomidebortezomibandlowdosedexamethasoneinlenalidomiderefractoryandproteasomeinhibitorexposedmyeloma AT lonials correctionpomalidomidebortezomibandlowdosedexamethasoneinlenalidomiderefractoryandproteasomeinhibitorexposedmyeloma AT laubachj correctionpomalidomidebortezomibandlowdosedexamethasoneinlenalidomiderefractoryandproteasomeinhibitorexposedmyeloma AT efeberaya correctionpomalidomidebortezomibandlowdosedexamethasoneinlenalidomiderefractoryandproteasomeinhibitorexposedmyeloma AT vesoledh correctionpomalidomidebortezomibandlowdosedexamethasoneinlenalidomiderefractoryandproteasomeinhibitorexposedmyeloma AT nookaak correctionpomalidomidebortezomibandlowdosedexamethasoneinlenalidomiderefractoryandproteasomeinhibitorexposedmyeloma AT rosenblattj correctionpomalidomidebortezomibandlowdosedexamethasoneinlenalidomiderefractoryandproteasomeinhibitorexposedmyeloma AT dossd correctionpomalidomidebortezomibandlowdosedexamethasoneinlenalidomiderefractoryandproteasomeinhibitorexposedmyeloma AT zakimh correctionpomalidomidebortezomibandlowdosedexamethasoneinlenalidomiderefractoryandproteasomeinhibitorexposedmyeloma AT bensmainea correctionpomalidomidebortezomibandlowdosedexamethasoneinlenalidomiderefractoryandproteasomeinhibitorexposedmyeloma AT herringj correctionpomalidomidebortezomibandlowdosedexamethasoneinlenalidomiderefractoryandproteasomeinhibitorexposedmyeloma AT liy correctionpomalidomidebortezomibandlowdosedexamethasoneinlenalidomiderefractoryandproteasomeinhibitorexposedmyeloma AT watkinsl correctionpomalidomidebortezomibandlowdosedexamethasoneinlenalidomiderefractoryandproteasomeinhibitorexposedmyeloma AT chenms correctionpomalidomidebortezomibandlowdosedexamethasoneinlenalidomiderefractoryandproteasomeinhibitorexposedmyeloma AT andersonkc correctionpomalidomidebortezomibandlowdosedexamethasoneinlenalidomiderefractoryandproteasomeinhibitorexposedmyeloma |